FDA Clearance Tracker · K192756
Aquadex FlexFlow System 2.0
Last checked: Nov 20, 2026Latest source record: Feb 24, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Feb 24, 2020
Substantially Equivalent
Time to decision
147 days
Received Sep 30, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K192756
- Device name
- Aquadex FlexFlow System 2.0
- Applicant
- Chf Solutions, Inc.
- Applicant location
- Eden Prairie, MN
- Received
- Sep 30, 2019
- Decided
- Feb 24, 2020
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.5860
- Specialty
- GI, Urology & NephrologyNephrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KDI. The earliest in FDA's data is K780527, decided Dec 20, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K192756
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Chf Solutions, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.